Back to 
JPMorgan Chase & Co.
JPMorgan Chase & Co.
IMNM
8 quarters
Position history for JPMorgan Chase & Co.'s holdings in Immunome, Inc.
Yes. JPMorgan Chase holds 1,848,548 shares of IMNM (Immunome), worth $39M, as of its Q2 2026 13F filing. It reduced the position by 929,288 shares (-33.5%) from Q1 2026. JPMorgan Chase has held IMNM in every 13F on record since Q3 2024, 8 quarterly filings.
Current Value
$39M
Current Shares
1.8M
Total Value Change
+$38.6M
Total Shares Change
+1.8M
Quarter-by-Quarter History
Other major holders of IMNM: FMR LLC, BlackRock, Inc.